Article

You have full text access to this OnlineOpen article

L-Arginine hydrochloride increases the solubility of folded and unfolded recombinant plasminogen activator rPA

  1. Alexander Tischer,
  2. Hauke Lilie,
  3. Rainer Rudolph†,
  4. Christian Lange*

Article first published online: 27 JUL 2010

DOI: 10.1002/pro.465

Issue

Protein Science

Protein Science

Volume 19, Issue 9, pages 1783–1795, September 2010

Additional Information

How to Cite

Tischer, A., Lilie, H., Rudolph, R. and Lange, C. (2010), L-Arginine hydrochloride increases the solubility of folded and unfolded recombinant plasminogen activator rPA. Protein Science, 19: 1783–1795. doi: 10.1002/pro.465

Author Information

  1. Institut für Biochemie und Biotechnologie, Martin-Luther-Universität Halle-Wittenberg, Kurt-Mothes-Str. 3, 06120 Halle (Saale), Germany

  1. †

    Deceased.

*Institut für Biochemie und Biotechnologie, Martin-Luther-Universität Halle-Wittenberg, Kurt-Mothes-Str. 3, 06120 Halle (Saale), Germany

Publication History

  1. Issue published online: 23 AUG 2010
  2. Article first published online: 27 JUL 2010
  3. Manuscript Revised: 7 JUL 2010
  4. Manuscript Accepted: 7 JUL 2010
  5. Manuscript Received: 18 MAY 2010

Funded by

  • Land Sachsen-Anhalt (Landesexzellenznetzwerk Strukturen und Mechanismen der biologischen Information-sverarbeitung)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (491K)

References

  • 1
    Rudolph R, Lilie H ( 1996) In vitro folding of inclusion body proteins. FASEB J 10: 49–56.
  • 2
    Fahnert B, Lilie H, Neubauer P ( 2004) Inclusion bodies: formation and utilization. Adv Biochem Eng Biotechnol 89: 93–142.
  • 3
    Lange C, Patil G, Rudolph R ( 2005) Ionic liquids as refolding additives: N′-alkyl and N′-(ω-hydroxyalkyl) N-methylimidazolium chlorides. Protein Sci 14: 2693– 2701.
    Direct Link:
  • 4
    Burgess RR ( 2009) Refolding solubilized inclusion body proteins. Methods Enzymol 463: 259–282.
  • 5
    Kiefhaber T, Rudolph R, Kohler H-H, Buchner J ( 1991) Protein aggregation in vivo: a quantitative model of the kinetic competition between folding and aggregation. Biotechnology (NY) 9: 825–829.
  • 6
    Lee JC, Timasheff SN ( 1981) The stabilization of proteins by sucrose. J Biol Chem 256: 7193–7201.
  • 7
    Gekko K, Timasheff SN ( 1981) Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures. Biochemistry 20: 4667–4676.
  • 8
    Arakawa T, Tsumoto K, Kita Y, Chang B, Ejima D ( 2007) Biotechnology applications of amino acids in protein purification and formulations. Amino Acids 33: 587–605.
  • 9
    Reddy KRC, Lilie H, Rudolph R, Lange C ( 2005) L-Arginine increases the solubility of unfolded species of hen egg white lysozyme. Protein Sci 14: 929–935.
    Direct Link:
  • 10
    Armstrong N, de Lencastre A, Gouaux E ( 1999) A new protein folding screen: application to the ligand binding domains of a glutamate and kainate receptor and to lysozyme and carbonic anhydrase. Protein Sci 8: 1475– 1483.
    Direct Link:
  • 11
    Chiu FF, Venkatesan N, Wu CR, Chou AH, Chen HW, Lian SP, Liu SJ, Huang CC, Lian WC, Chong P, Leng CH ( 2009) Immunological study of HA1 domain of hemagglutinin of influenza H5N1 virus. Biochem Biophys Res Commun 383: 27–31.
  • 12
    Wang XT, Engel PC ( 2009) An optimised system for refolding of human glucose 6-phosphate dehydrogenase. BMC Biotechnol 9: 19–29.
  • 13
    Buchner J, Rudolph R ( 1991) Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli. Biotechnology (NY) 9: 157–162.
  • 14
    Rudolph R, Fischer S ( 1990) Process for obtaining renatured proteins. US Patent 4,933,434.
  • 15
    Lange C, Rudolph R ( 2009) Suppression of protein aggregation by L-arginine. Curr Pharm Biotechnol 10: 408–414.
  • 16
    Cohn EJ ( 1920) The relation between the iso-electric point of a globulin and its solubility and acid combining capacity in salt solution. Proc Natl Acad Sci USA 6: 256–263.
  • 17
    Green AA ( 1931) Studies in the physical chemistry of the proteins: VIII. The solubility of haemoglobin in concentrated salt solutions. A study of the salting out of proteins. J Biol Chem 93: 495–516.
  • 18
    Green AA ( 1931) Studies in the physical chemistry of the proteins. IX. The effect of electrolytes on the solubility of haemoglobin in solutions of varying hydrogen ion activity with a note on the comparable behaviour of casein. J Biol Chem 93: 517–542.
  • 19
    Arakawa T, Timasheff SN ( 1987) Abnormal solubility behavior of beta-lactoglobulin: salting-in by glycine and NaCl. Biochemistry 26: 5147–5153.
  • 20
    Ruckenstein E, Shulgin IL ( 2006) Effect of salts and organic additives on the solubility of proteins in aqueous solutions. Adv Colloid Interface Sci 123–126: 97–103.
  • 21
    Hofmeister F ( 1888) Zur Lehre von der Wirkung der Salze. II. Arch Exp Pathol Pharmakol 24: 247–260.
  • 22
    Nandi PK, Robinson DR ( 1972) The effects of salts on the free energy of the peptide group. J Am Chem Soc 94: 1299–1308.
  • 23
    Riés-Kautt MM, Ducruix AF ( 1989) Relative effectiveness of various ions on the solubility and crystal growth of lysozyme. J Biol Chem 264: 745–748.
  • 24
    Zangi R ( 2010) Can salting-in/salting-out ions be classified as chaotropes/kosmotropes? J Phys Chem B 114: 643–650.
  • 25
    Timasheff SN, Inoue H ( 1968) Preferential binding of solvent components to proteins in mixed water-organic solvent systems. Biochemistry 7: 2501–2513.
  • 26
    Timasheff SN ( 2002) Protein hydration, thermodynamic binding, and preferential hydration. Biochemistry 41: 13473–13482.
  • 27
    Baynes BM, Wang DIC, Trout BL ( 2005) Role of arginine in the stabilization of proteins against aggregation. Biochemistry 44: 4919–4925.
  • 28
    Kohnert U, Rudolph R, Verheijen JH, Weening-Verhoeff EJD, Stern A, Prinz H, Lechner M, Kresse G-B, Buckel P, Fischer S ( 1992) Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022. Protein Eng 5: 93–100.
  • 29
    Hu CK, Kohnert U, Stürzebecher J, Fischer S, Llinás M ( 1996) Complexation of tissue plasminogen activator protease with benzamidine-type inhibitors: interference by the kringle 2 module. Biochemistry 35: 3270–3276.
  • 30
    Hofrichter J, Ross PD, Eaton WA ( 1974) Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease. Proc Natl Acad Sci USA 71: 4864–4868.
  • 31
    Baynes BM, Trout BL ( 2004) Rational design of solution additives for the prevention of protein aggregation. Biophys J 87: 1631–1639.
  • 32
    Arakawa T, Ejima D, Tsumoto K, Obeyama N, Tanaka Y, Kita Y, Timasheff SN ( 2007) Suppression of protein interactions by arginine: a proposed mechanism of the arginine effects. Biophys Chem 127: 1–8.
  • 33
    Taneja S, Ahmad F ( 1994) Increased thermal stability of proteins in the presence of amino acids. Biochem J 303: 147–153.
  • 34
    Arakawa T, Tsumoto K ( 2003) The effects of arginine on refolding of aggregated proteins: not facilitate refolding, but suppress aggregation. Biochem Biophys Res Commun 304: 148–152.
  • 35
    Nakakido M, Tanaka Y, Mitsuhori M, Kudou M, Ejima D, Arakawa T, Tsumoto K ( 2008) Structure-based analysis reveals hydration changes induced by arginine hydrochloride. Biophys Chem 137: 105–109.
  • 36
    Das U, Gururao H, Abdul ES, Pallavi M, Das T, Pasha S, Mann M, Ganguli M, Verma AK, Bhat R, Chandrayan SK, Ahmed S, Sharma S, Kaur P, Singh TP, Srinivasan A ( 2007) Inhibition of protein aggregation: supramolecular assemblies of arginine hold the key. PLoS One 11: e1176.
  • 37
    Gill SC, von Hippel PH ( 1989) Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem 182: 319–326.
  • 38
    Pace CN ( 1986) Determination and analysis of urea and guanidine hydrochloride denaturation curves. Methods Enzymol 131: 266–280.
  • 39
    Wahlund KG, Giddings JC ( 1987) Properties of an asymmetrical flow field-flow fractionation channel having one permeable wall. Anal Chem 59: 1332–1339.
  • 40
    Fraunhofer W, Winter G ( 2004) The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics. Eur J Pharm Biopharm 58: 369–383.
  • 41
    Roda B, Zattoni A, Reschiglian P, Moon MH, Mirasoli M, Michelini E, Roda A ( 2009) Field-flow fractionation in bioanalysis: a review of recent trends. Anal Chim Acta 635: 132–143.
  • 42
    Harding SE, Jumel K ( 1998) Light scattering. Curr Protoc Protein Sci 7.8.1–7.8.14.
View Full Article (HTML) Get PDF (491K)